BB BIOTECH AG 13D and 13G filings for Ionis Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 8:34 pm Sale |
2024-09-30 | 13G | Ionis Pharmaceuticals, Inc. IONS |
BB BIOTECH AG | 7,850,000 5.000% |
-740,000 (-8.61%) |
Filing |
| 2024-02-13 06:09 am Sale |
2023-12-31 | 13G | Ionis Pharmaceuticals, Inc. IONS |
BB BIOTECH AG | 8,590,000 6.000% |
-1,045,000 (-10.85%) |
Filing |
| 2023-02-14 4:07 pm Sale |
2022-12-31 | 13G | Ionis Pharmaceuticals, Inc. IONS |
BB BIOTECH AG | 9,635,000 6.800% |
-597,973 (-5.84%) |
Filing |
| 2022-02-11 4:42 pm Purchase |
2021-12-31 | 13G | Ionis Pharmaceuticals, Inc. IONS |
BB BIOTECH AG | 10,232,973 7.200% |
2,012,973 (+24.49%) |
Filing |
| 2021-02-12 4:07 pm Purchase |
2020-12-31 | 13G | Ionis Pharmaceuticals, Inc. IONS |
BB BIOTECH AG | 8,220,000 5.900% |
225,045 (+2.81%) |
Filing |